ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag funding evolution nih culture

Mail
N/A | Jan 1, 2011 | 6 min read
A selection of comments from our readers
Opinion: Ethics Training in Science
James Hicks | May 14, 2013 | 4 min read
The NIH has required researchers to receive instruction about responsible conduct for more than 20 years, but misconduct is still on the rise.
Opinion: The Politics of Science and Racism
Sadye Paez and Erich D. Jarvis | Aug 18, 2020 | 7 min read
Race has been used to segment humanity and, by extension, establish and enforce a hierarchy in science. Individual and institutional commitments to racial justice in the sciences must involve political activity.
Bioengineering and Imaging Merge at NIH
Steve Bunk | Sep 16, 2001 | 7 min read
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) will become fully functional by Oct. 31, burying a two-decade struggle between powerful foes. That fight reached crisis point on the last working day of 2000, when former President Bill Clinton was faced with deciding whether to sign a federal law sanctioning the 19th institute at the National Institutes of Health. To approve NIBIB, he would have to override the opposition of numerous scientific groups and of his Health and
New Products
The Scientist Staff | Feb 5, 1995 | 3 min read
The Ni-NTA spin columns provide purification of 6xHis-tagged proteins from small-scale expression cultures. Available in two formats--separately without reagents or as a complete kit--they can be used in experimental situations requiring small-scale expression, functional screening, and rapid purification of engineered and recombinant proteins. Each can purify up to 100 fg of 6xHis tagged protein under native or denaturing conditions. According to the manufacturer, this procedure allows 12 mini
Thirty Years of Lab Safety
Michal Barski | Oct 1, 2016 | 3 min read
From mouth pipetting to automated liquid handling, life-science labs have gotten much safer over the past three decades.
Can Viruses in the Genome Cause Disease?
Katarina Zimmer | Jan 1, 2019 | 10+ min read
Clinical trials that target human endogenous retroviruses to treat multiple sclerosis, ALS, and other ailments are underway, but many questions remain about how these sequences may disrupt our biology.
march 2019 the scientist profile
Master Decoder: A Profile of Kári Stefánsson
Anna Azvolinsky | Mar 1, 2019 | 9 min read
A neurologist by training, Stefánsson founded Iceland-based deCODE Genetics to explore what the human genome can tell us about disease and our species’ evolution.
Genome Investigator Craig Venter Reflects On Turbulent Past And Future Ambitions
Karen Young Kreeger | Jul 23, 1995 | 8 min read
And Future Ambitions Editor's Note: For the past four years, former National Institutes of Health researcher J. Craig Venter has been a major figure in the turbulent debates and scientific discoveries surrounding the study of genes and genomes. Events heated up in 1991, when NIH attempted to patent gene fragments, which were isolated using Venter's expressed sequence tag (EST)/complementary DNA (cDNA) approach for discovering human genes (M.A. Adams et al., Science, 252:1651-6, 1991). NIH's mo
What a tangled web we weave
Barbara Oakley | Apr 9, 2009 | 3 min read
Understanding unethical behavior through genetics, biology and evolution

Run a Search

ADVERTISEMENT